Roca Therapeutics focuses on the research and development of small medicines to treat severe, life-threatening diseases brought on by hypervascularization and the immunosuppression produced by macrophages M2.

Biotechnology

Health Care

Therapeutics

Roca Therapeutics

Office 112 focuses on research and engineering studies, contributing innovative solutions in technology and development.

Maeva Dufies

Roberto De Ponti

Gilles Pagès

Zaki Sellam

Sergio Roman Roman

Olivier Loget

Stéphanie Baillif

Arnaud Jacquel

Patrick Auberger

Andréas Bikfalvi

Rachid Benhida

Cyril Ronco

Lauris Gastaud

The Advisory Team at Roca Therapeutics consists of seasoned experts who provide strategic guidance and insights to advance the company’s innovative drug development pipeline. They leverage their extensive experience in pharmacology, clinical research, and regulatory affairs to help shape Roca's therapeutic strategies, ensure alignment with industry standards, and facilitate collaborations that enhance the company's mission to combat severe diseases linked to hypervascularization and M2 macrophage immunosuppression.

Advisory Team

This department provides strategic oversight and governance for the organization.

Leadership Board

Roca Therapeutics

Org chart

Board & advisors

Teams

Advisory Team

Leadership Board

Offices

Roca Therapeutics

Org chart

Board & advisors

Teams

Advisory Team

Leadership Board

Offices

Related companies